In this study, hnRNPK expression in clinical NPC samples was initially evaluated by using the GEPIA (http://gepia.cancer-pku.cn) and Oncomine (https://www.oncomine.org/). The gene discussed is HNRNPK; the disease is nasopharyngeal carcinoma.